MintNeuro
MintNeuro is a London-based neurotechnology company, spun out of Imperial College London in 2022, that designs and supplies purpose-built ASIC chips for implantable neural interface devices targeting epilepsy, Parkinson's, depression, and other neurological conditions for medical device developers.
- Company typePrivate
- Founded2022
- HeadquartersLondon, United Kingdom
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What MintNeuro does
MintNeuro (Mint Neurotechnologies Ltd) is a London-based neurotechnology semiconductor company spun out of Imperial College London in April 2022. The company designs and supplies purpose-built Application-Specific Integrated Circuits (ASICs) for implantable neural interface devices, serving medical device developers and brain-computer interface (BCI) companies building systems for neurological and psychiatric conditions. The technology stack combines low-power mixed-signal chip design with on-chip signal processing tailored to neural recording and stimulation, with intellectual property derived from more than 20 years of research at Imperial College's neural engineering laboratories.
The company's product architecture is built around a modular ASIC platform intended to be configurable across different therapeutic indications, reducing the integration burden for implant developers. Manufacturing is conducted through foundry partners, including TSMC, and the company maintains active research relationships with academic groups at Imperial College London and King's College London. Disclosed programmes span epilepsy, Parkinson's disease, treatment-resistant depression, stroke, dementia, and urinary incontinence, indicating a deliberate horizontal platform strategy rather than a single-application product.
MintNeuro operates as a business-to-business component supplier, monetising through chip sales, design services, and multi-year commercial supply agreements with device OEMs. Its first disclosed commercial anchor is a multi-year supply agreement with Motif Neurotech, a BCI developer focused on treatment-resistant depression with an active US FDA clinical pathway. The company's financing to date is dominated by non-dilutive grant funding from UK sources (NIHR, Innovate UK) and ARIA, totalling approximately £18.3M, supplemented by a £1M seed equity round led by Empirical Ventures in late 2024.
MintNeuro firmographics
Firmographics- Name
- MintNeuro
- Legal name
- Mint Neurotechnologies Ltd
- Website
- https://mintneuro.com
- Company type
- Private
- Founded year
- 2022
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- MintNeuro is a London-based neurotechnology company, spun out of Imperial College London in 2022, that designs and supplies purpose-built ASIC chips for implantable neural interface devices targeting epilepsy, Parkinson's, depression, and other neurological conditions for medical device developers.
- Ownership category
- akta.pro rank
MintNeuro industry classification
Industry- Product category
- Neural Implant Semiconductors
- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Semiconductor and Related Device Manufacturing (334413)
- SIC
- Electromedical & Electrotherapeutic Apparatus (3845)
- akta.pro primary industry
- System-on-Chip (SoC) Platforms (Mobile/Consumer/Embedded) (HDAHAJAC)
- akta.pro secondary industries
- Implantable Neuromodulation & Neurostimulation (SCS/DBS/VNS/PNS) (HLAHAEAK), Analog Front-End (AFE) ICs (Sensor/Medical/Industrial AFE) (HDAHAIAJ)
Keywords
Where MintNeuro is headquartered
LocationHeadquarters
- HQ city
- London
- HQ country
- United Kingdom
- HQ region
- Europe
Offices1 record
Markets served
MintNeuro business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Personnel, Operations, Supply Chain
Revenue model
- Semiconductor Chip Sales: Sale of purpose-built integrated circuits to medical device manufacturers for integration into implantable neural devices. Revenue derived from chip supply agreements with device partners covering pre-clinical, clinical, and commercial phases.
- Commercial Supply Agreements: Multi-year commercial supply agreements with device companies providing forward revenue visibility tied to development and clinical trial trajectories. The Motif Neurotech partnership exemplifies this model.
- Research Grants and Government Funding: Non-dilutive funding from UK government agencies (ARIA, Innovate UK, NIHR) supporting R&D projects. ARIA awarded £17 million across three projects; NIHR awarded £1.4 million for epilepsy monitoring device development.
Go-to-market motion3 records
Distribution channels4 records
Marketing channels6 records
MintNeuro product offering
Product offeringCore offering
MintNeuro designs and manufactures purpose-built semiconductor integrated circuits (ASICs) for active implantable medical devices and brain-computer interfaces. Its modular chip platform supports neural signal acquisition (EEG, EMG, ECoG, LFP), ultra-low-power management, wireless data transfer, on-chip signal processing, and electrical stimulation with integrated safety features, enabling device partners to build neural implants up to 1,000x smaller than current technologies.
Product overview
MintNeuro is a semiconductor technology company that offers a unified modular chip platform for neural implants. The platform consists of purpose-built integrated circuits designed to enable minimally invasive, scalable, and accessible neural devices. The platform provides core capabilities including neural signal acquisition (EEG, EMG, ECoG, LFP), power management and wireless data transfer, on-chip signal processing and data reduction, electrical stimulation and safety control, and integrated safety features. All components are designed to medical-grade standards and are scalable from preclinical research to commercial implant systems.
Differentiator
Problem solved
Functional benefit
Products and services
- Modular Chip Platform for Neural Implants A purpose-built semiconductor integrated circuit (ASIC) platform for neural implants that supports neural signal acquisition (EEG, EMG, ECoG, LFP), ultra-low-power management, wireless data transfer, on-chip signal processing and data reduction, electrical stimulation, and integrated safety features. The platform is designed to medical-grade standards, manufactured through trusted foundry partnerships (e.g., TSMC), and is scalable from preclinical research to commercial implant systems. It is sold B2B to medical device companies, research institutions, and consortia building active implantable medical devices and brain-computer interfaces.
Quantifiable outcome
- Devices up to 1,000x smaller than current technologies
- +2 more outcomes
Companies that use MintNeuro
Customer profileNamed customers1 record
Segments4 records
Ideal customer profiles3 records
MintNeuro technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature7 records
MintNeuro partnerships and signals
Strategic signalPartnerships
Six partnerships are on record, tiered core and supporting.
- Motif NeurotechcoreStrategic partnership combining MintNeuro's miniaturized neural interface chip technology with Motif's clinical-stage therapeutic BCI implant platform. The collaboration includes a multi-year commercial supply agreement covering pre-clinical, early clinical, and pivotal trial phases for Motif's DOT device (blueberry-sized implantable brain stimulator for treatment-resistant depression). MintNeuro's chips enable neuromodulation, real-time monitoring, and closed-loop stimulation functions. Motif has received FDA approval to begin US clinical trials.
- TSMC (Taiwan Semiconductor Manufacturing Company)coreManufacturing partnership with TSMC for production of MintNeuro's semiconductor chips. Chips are manufactured through close partnership with trusted foundries to ensure medical-grade quality and reliability.
- UK and US Academic InstitutionssupportingCollaborations with UK and US academic institutions as part of ARIA-funded projects developing chip-scale neurotechnologies for AI-enhanced brain stimulation, distributed wireless neural implant networks, and minimally-invasive temporal interference stimulation systems.
- Amber Therapeuticscore£800k strategic partnership under the GOLD project (Reconfigurable semiconductor technology for advanced neural implants) supported by Innovate UK Smart grant. Co-development of a modular neural chipset designed to combine high-level performance with miniaturized footprints for implantable medical devices, initially targeting treatment of mixed urinary incontinence.
- Imperial College LondoncoreAcademic research partnership leveraging Imperial's neural implant technology developed over two decades. MintNeuro spun out from Imperial in April 2022. The partnership provides access to labs, entrepreneurship training, and collaborative grant applications with partner universities. Professor Timothy Constandinou serves as CTO and is leading research programs.
- King's College LondonsupportingResearch partner in the £1.4M NIHR i4i PDA project for wireless intracranial neuromonitoring device for drug-resistant epilepsy. Dr Antonio Valentín serves as project co-lead alongside Professor Timothy Constandinou.
Scale indicators8 records
Recent moves7 records
Expansion highlights6 records
MintNeuro competitors and assessment
Company assessmentDirect peers
- CorTec: CorTec designs and manufactures implantable neurotechnology components, including hermetic housings, electrodes, and electronic modules for brain-computer interfaces and neuromodulation. Like MintNeuro, CorTec supplies enabling hardware to researchers and medical device developers building active implantable systems.
Broad incumbents
- Blackrock Neurotech: Blackrock Neurotech is an established implantable BCI platform with custom neural recording electronics and arrays used in research and clinical applications. It is comparable to MintNeuro as a vertically integrated developer of neural implant electronics targeting brain-computer interfaces.
- Paradromics: Paradromics is developing a high-data-rate implantable BCI with custom ASICs designed for high-channel-count neural recording. It is comparable to MintNeuro as a competitor building purpose-built chip technology for next-generation neural implants.
- Synchron: Synchron develops a minimally invasive vascular BCI platform and is one of the more advanced players in the implantable BCI space. It is comparable to MintNeuro as a competitor targeting scalable, less-invasive brain-computer interfaces using purpose-built electronics.
- Neuralink: Neuralink is developing a high-channel-count implantable BCI with custom chip and packaging technology designed in-house. It is comparable to MintNeuro as a competitor building purpose-built semiconductor and packaging for brain implants.
- Saluda Medical: Saluda Medical is a commercial-stage neuromodulation company with the Evoke closed-loop spinal cord stimulation system featuring custom ASICs for neural recording and responsive stimulation. It is comparable to MintNeuro as a device company investing in custom neuromodulation silicon.
- NeuroPace: NeuroPace markets the RNS System, the first FDA-approved closed-loop responsive neurostimulator for epilepsy, with proprietary custom ASICs that detect and respond to neural activity. It is comparable to MintNeuro as a vertically integrated player combining custom neuromodulation chips with implantable therapy devices.
- Medtronic (Neuromodulation): Medtronic operates one of the largest neuromodulation businesses (Activa PC DBS, Intellis SCS, Percept PC with BrainSense), with significant in-house chip and system design capability. It is comparable to MintNeuro as an incumbent incumbent in implantable neurostimulation that could compete with or partner around specialized neural implant ASICs.
- Boston Scientific (Neuromodulation): Boston Scientific's Neuromodulation division (Precision SCS, Vercise DBS, WaveWriter) develops closed-loop stimulation systems with proprietary electronics. It is comparable to MintNeuro as a large incumbent in implantable neurostim devices that designs its own neural interface electronics.
Emerging players
- Cambridge NeuroTech: Cambridge NeuroTech produces high-density silicon neural probes and accompanying electronics for neural recording research. It is comparable to MintNeuro as an adjacent emerging supplier of high-performance neural interface hardware to research and device development customers.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks7 records
Key highlights7 records
Customer concentration
MintNeuro social profiles
Digital presenceMintNeuro financial estimates
Financial estimateRevenue estimate
Valuation estimate
MintNeuro leadership team
Management profileNumber of profiles
Profiles6 records
MintNeuro funding detail
Funding detailFunding overview
Funding rounds2 records
Investors6 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
MintNeuro M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about MintNeuro
What does MintNeuro do?
MintNeuro designs and manufactures purpose-built semiconductor integrated circuits (ASICs) for active implantable medical devices and brain-computer interfaces. Its modular chip platform supports neural signal acquisition (EEG, EMG, ECoG, LFP), ultra-low-power management, wireless data transfer, on-chip signal processing, and electrical stimulation with integrated safety features, enabling device partners to build neural implants up to 1,000x smaller than current technologies.
Is MintNeuro a public or private company?
MintNeuro is a private company. It is classified as venture growth investor backed and is currently operating.
When was MintNeuro founded?
MintNeuro was founded in 2022. It employs 11 to 50 people.
Where is MintNeuro based?
MintNeuro is headquartered in London, United Kingdom, in the Europe region.
How does MintNeuro make money?
Three revenue lines are on record. Semiconductor Chip Sales are the primary driver. The others are commercial Supply Agreements and research Grants and Government Funding.
Who are MintNeuro's main competitors?
CorTec is listed as a direct peer. Broad incumbents are Blackrock Neurotech, Paradromics, Synchron, Neuralink, Saluda Medical, NeuroPace, Medtronic (Neuromodulation) and Boston Scientific (Neuromodulation). Cambridge NeuroTech is listed as an emerging player.
Does MintNeuro have an API?
No public API is recorded for MintNeuro.
What industry is MintNeuro in?
MintNeuro's product category is Neural Implant Semiconductors. Its primary akta.pro industry code is HDAHAJAC, System-on-Chip (SoC) Platforms (Mobile/Consumer/Embedded), with a secondary code of HLAHAEAK, Implantable Neuromodulation & Neurostimulation (SCS/DBS/VNS/PNS). Its NAICS code is 334510 and its SIC code is 3845.